247 related articles for article (PubMed ID: 29569296)
1. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
[TBL] [Abstract][Full Text] [Related]
2. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
[No Abstract] [Full Text] [Related]
3. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
[TBL] [Abstract][Full Text] [Related]
4. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease.
Hren MG; Guenin S; Khattri S
J Am Acad Dermatol; 2024 Jul; 91(1):138-140. PubMed ID: 38494153
[No Abstract] [Full Text] [Related]
5. Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.
Samorano LP; Hanifin JM; Simpson EL; Leshem YA
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):522-3. PubMed ID: 25510643
[No Abstract] [Full Text] [Related]
6. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
7. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
Nakayama C; Fujita Y; Watanabe M; Shimizu H
J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
9. Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.
Weiss D; Schaschinger M; Ristl R; Gruber R; Kopp T; Stingl G; Bangert C
J Am Acad Dermatol; 2017 Jan; 76(1):91-97.e3. PubMed ID: 27745907
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases.
de Souza A; Ali-Shaw T; Reddy SM; Fiorentino D; Strober BE
Br J Dermatol; 2013 Jan; 168(1):210-2. PubMed ID: 23278559
[TBL] [Abstract][Full Text] [Related]
11. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
12. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
[TBL] [Abstract][Full Text] [Related]
13. Mutual antagonism of T cells causing psoriasis and atopic eczema.
Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
[No Abstract] [Full Text] [Related]
14. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation.
Choy DF; Hsu DK; Seshasayee D; Fung MA; Modrusan Z; Martin F; Liu FT; Arron JR
J Allergy Clin Immunol; 2012 Dec; 130(6):1335-43.e5. PubMed ID: 22920495
[TBL] [Abstract][Full Text] [Related]
15. Ustekinumab associated with flares of psoriatic arthritis.
Stamell EF; Kutner A; Viola K; Cohen SR
JAMA Dermatol; 2013 Dec; 149(12):1410-3. PubMed ID: 24132520
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Guttman-Yassky E; Krueger JG
Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.
Khattri S; Brunner PM; Garcet S; Finney R; Cohen SR; Oliva M; Dutt R; Fuentes-Duculan J; Zheng X; Li X; Bonifacio KM; Kunjravia N; Coats I; Cueto I; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
Exp Dermatol; 2017 Jan; 26(1):28-35. PubMed ID: 27304428
[TBL] [Abstract][Full Text] [Related]
19. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
20. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
Homey B
Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
